Our Opinion

Metagenomi Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company stated in the following report that they exploit animals for product testing.

“Demonstrated dose-dependent saturating levels of hepatocyte genome editing of HAO1 in normal mice” (Page 18) Read the full document

Company Description

Metagenomi, Inc., a genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States. The company’s genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems, such as prime editing systems and clustered regularly interspaced short palindromic repeat-associated transposases. The company was incorporated in 2016 and is based in Emeryville, California.

Company Website: https://metagenomi.co